DRUG · Mapped RxNorm record
Naltrexone
Normalized identity: naltrexoneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
NCT03132571
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Bupropion
Normalized identity: bupropionView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedNaltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Obesityverified · MONDO: obesity disorder
Interventions
NaltrexoneDRUG · verified · RxNorm: naltrexone
BupropionDRUG · verified · RxNorm: bupropion
PlaceboOTHER
Sponsors & collaborators
Yale Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03132571 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.